CARCINOMA, TRANSITIONAL CELL
Clinical trials for CARCINOMA, TRANSITIONAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, TRANSITIONAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, TRANSITIONAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug combo shows promise against bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, either alone or combined with other cancer treatments, in people with urothelial cancer (a type of bladder and urinary tract cancer). The study included patients with advanced cancer that had spread, as well as tho…
Matched conditions: CARCINOMA, TRANSITIONAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New bladder cancer treatment put to the test
Disease control TerminatedThis study tested a drug called enfortumab vedotin for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug was placed directly into the bladder using a thin tube. The main goals were to check for side effects and see if the drug helps treat the…
Matched conditions: CARCINOMA, TRANSITIONAL CELL
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC